Lion Point Capital, LP Humacyte, Inc. Transaction History
Lion Point Capital, LP
- $9.73 Million
- Q1 2025
A detailed history of Lion Point Capital, LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 83,500 shares of HUMA stock, worth $206,245. This represents 1.46% of its overall portfolio holdings.
Number of Shares
83,500Holding current value
$206,245% of portfolio
1.46%Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
188Shares Held
60.4MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$17.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$16.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$10.5 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.94 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.76 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $254M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...